Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin vs cisplatin plus gemcitabine in advanced lung squamous cell carcinoma
ChiCTR-IPR-16008489Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jun 2016
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Pulmonary squamous cell carcinoma comparing Nedaplatin + gemcitabine with Cisplatin + gemcitabine (2 arms). Primary endpoints: Progression-free survival (PFS) and Objective response rate (ORR). Started Jun 2016; status: recruiting.
02
Drugs
nedaplatincisplatingemcitabine
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR-IPR-16008489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008489.